Abstract
During 2020, Coronavirus Disease-19 (COVID-19) incidence fluctuated in two clear waves across the spring and autumn periods. This study was designed to compare the maternal and perinatal clinical outcomes in obstetrics patients with COVID-19 between the two waves of infection in Spain. We conducted an observational, analytical, ambispective cohort study with longitudinal follow-up of mothers with confirmed SARV-CoV-2 infection from different hospitals in our country between March–November 2020. We recruited 1295 pregnant women with SARS-CoV2 infection from 78 hospitals, 846 (65.3%) of whom were diagnosed during the first wave and 449 (34.7%) during the second wave. Our results show that patients developing COVID-19 during the first wave had more symptoms at triage, early in pregnancy with greater rates of COVID-19-related maternal morbidity; caesarean section and preterm birth in the first wave. We register two cases of maternal mortality and only during the first wave. Maternal morbidity events showed a strong link to perinatal mortality events in the first wave compared to the second wave, in which maternal morbidity was more associated with pneumonia. Likewise, maternal morbidity showed a strong correlation with perinatal morbidity events in both waves. We describe the differences between the patients’ profiles and management between the two waves and related to maternal and perinatal outcomes. Differences were also observed in the management of pregnant women with COVID-19. Thus, there were fewer caesarean sections, and maternal and perinatal morbidity events were reduced in the second wave, while the impacts of respiratory symptoms and their severity, including a greater need for maternal treatment, were greater in this last period. Identifying the impact that changes in the profile as well as in the treatment have on maternal–perinatal morbidity and mortality will help improve the well-being of our patients and their newborns.
Highlights
The emergence and rapid global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) is responsible for the pandemic in which we are immersed
Maternal morbidity events showed a strong link to perinatal mortality events in the first wave (OR: 8.3) compared to the second wave, in which maternal morbidity was more associated with pneumonia (OR: 9.4)
We propose several factors leading to less severe cases of COVID-19 in our patients in the second wave, implying a lower risk of maternal–perinatal morbidity events
Summary
The emergence and rapid global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) is responsible for the pandemic in which we are immersed. Spain is one of the most severely affected European countries after Russia, France or the UK, with its 3,279,825 confirmed cases, including 75,199 deaths so far [1]. Physiologic or immunologic changes during pregnancy may have systemic effects that predispose women to complications from respiratory infections that lead to maternal and fetal mortality and morbidity [2,3]. Notwithstanding, studies have shown that pregnancy in itself may be a risk factor for death, pneumonia and ICU admission in SARS-CoV-2-infected women of reproductive age [6]. A major risk factor for an adverse outcome in patients with COVID-19 is the presence of comorbidities, including advanced age [7], diabetes, hypertension and obesity [8]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
